HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Adjusts Price Target To $7
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on Applied DNA Sciences (APDN), adjusting the price target to $7 from $1.5.

May 13, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has maintained a Buy rating on Applied DNA Sciences, significantly raising the price target from $1.5 to $7, indicating a strong positive outlook on the company's future performance.
The substantial increase in the price target from $1.5 to $7 by a reputable analyst firm like HC Wainwright & Co. suggests a strong conviction in the company's growth potential and operational improvements. This endorsement is likely to positively influence investor sentiment and could lead to a short-term increase in stock price as the market adjusts to the new valuation expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100